Welcome to our Press Archive section below you will find Archive stories and posts and all types of information from the past. Please feel free to browse and enjoy.
- All
- Ad-hoc
- Finance
- Innovation
- Press
31Oct2025
Anne-Kathrin Stoller to become new CEO at Bachem
Bachem appoints Anne-Kathrin Stoller as new CEO effective January 1, 2026, succeeding Thomas Meier a...
23Oct2025
Bachem announces progress in Building K start-up and expansion of its site in Vista, CA
Bachem reports progress on Building K in Bubendorf and expands its Vista, CA site to boost peptide p...
20Aug2025
Bachem expands Corporate Executive Committee to include Chief Operations Officer role
The Bachem Group (SIX: BANB) announced today that Hans Van Hees, currently Chief Operations Officer ...
24Jul2025
Bachem shows strong growth in the first half of 2025
Bachem shows strong growth in the first half of 2025. Group sales showed strong growth reaching CHF ...
30Apr2025
Bachem Annual General Meeting 2025
All proposals of the Board of Directors have been approved at Annual General Meeting 2025...
03Apr2025
Additional member for the Board of Directors of Bachem Holding AG
The Board of Directors will recommend the election of Dr. Simone Wyss Fedele, CEO of Switzerland Glo...
27Feb2025
Bachem increases sales and profitability
The Bachem Group (SIX: BANB) increased sales in Swiss francs by 4.8% to CHF 605.3 million in 2024. I...
20Sep2024
Bachem at Swiss Technology Award 2024 – Industry Innovation with MCSGP
Bachem is delighted to announce that we have reached the final of the Swiss Technology Award 2024 wi...
19Aug2024
Water-based SPPS – Advancing Sustainable Peptide Synthesis
SPPS traditionally occurs in organic solvents. Water-based SPPS, however, replaces these solvents wi...
25Jul2024
Bachem with slight sales growth in the first half of 2024. Outlook confirmed for full year.
The Bachem Group (SIX: BANB) achieved sales of CHF 240.3 million in the first half of 2024....
30Apr2024
Voices on Bachem’s Innovation Culture
At Bachem, innovation isn't just a buzzword – it's ingrained in our culture. We want to foster a w...
24Apr2024
Bachem Annual General Meeting 2024
Bachem Holding AG (“Bachem”, SIX: BANB) announced today that its Annual General Meeting (AGM) 20...
07Mar2024
Bachem continues to grow and increases dividend
Bachem presents strong growth figures for 2023. Group sales rose by to CHF 577.3 million and by 12.8...
01Feb2024
A conversation with the founders of ChromaCon
A Conversation with ChromaCon Founders on Innovation, Partnership & the Future of Continuous Chromat...
10Jan2024
The era of large-scale peptide & oligo purification with MCSGP has begun
Groundbreaking large-scale TIDES purification with MCSGP - transforming drug manufacturing with sust...
29Nov2023
Scalable tag-assisted one-pot liquid-phase oligo synthesis
Using tag-assisted one-pot liquid-phase oligonucleotide synthesis for high amount of oligos with low...
27Oct2023
Back to stirred vessels and on to metric tons of oligonucleotides
Stirred-bed technology represents an economical solution to manufacture oligonucleotides on a large...
15Sep2023
Bachem reorganizes responsibilities in the Corporate Executive Committee and increases focus on capacity expansion and efficiency improvement
Bachem reorganizes responsibilities in the CEC and concentrates even more on expanding capacity and ...
Contact us
"*" indicates required fields